Efficacy and safety of intravenous theophylline administration for treatment of mild acute exacerbation of bronchial asthma

Respirology

Volumn 10, Issue 4, 2005, Pages 491-496

  Yamauchi, Kohei ^a   Kobayashi, Hitoshi ^a   Tanifuji, Yukio ^a   Yoshida, Takumi ^a   Pian, Huan Deng ^a   Inoue, Hiroshi ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Asthma; Ethylenediamine; Exacerbation; Theophylline

Indexed keywords

THEOPHYLLINE; BRONCHODILATING AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; ASTHMA; BORG SCALE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SUSTAINED RELEASE PREPARATION; ACUTE DISEASE; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ASTHMA; BRONCHODILATOR AGENTS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; THEOPHYLLINE; TREATMENT OUTCOME;

EID: 33644837750     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2005.00730.x     Document Type: Article

References (24)

1. Mitenko PA Ogilvie RI. Rational intravenous doses of theophylline. N. Engl. J. Med. 1973 289 : 600 3.
2. Wrenn K Slovis CM Murphy F Greenberg RS. Aminophylline therapy for acute bronchospastic disease in the emergency room. Ann. Intern. Med. 1991 115 : 241 7.
3. Huang D O'Brien RG Harman E et al. Does aminophylline benefit adults admitted to the hospital for an acute exacerbation of asthma? Ann. Intern. Med. 1993 119 : 1155 60.
4. Ohta K Nakagome K Akiyama K et al. Aminophylline is effective on acute exacerbations of asthma in adults - objective improvements in peak flow, spirogram, arterial blood gas measurements and lung sounds. Clin. Exp. Allergy 1996 26 ( Suppl. 2 32 7.
5. Nuhoglu Y Dai A Barlan IB Basaran MM. Efficacy of aminophylline in the treatment of acute asthma exacerbation in children. Ann. Allergy Asthma Immunol. 1998 80 : 395 8.
6. Makino S Furusyou K Miyamoto T. Asthma Prevention: Management Guideline, Revised 1998, Kyowakikaku, Tokyo, 2000 84 8.
7. Nakazawa T Matsui S. Ethylenediamine-induced late asthmatic responses. J. Asthma 1990 27 : 207 12.
8. Terzian CG Simon PA. Aminophylline hypersensitivity apparently due to ethylenediamine. Ann. Emerg. Med. 1992 21 : 312 14.
9. Asakawa H Araki T Yamamoto N et al. Allergy to ethylenediamine and steroid. J. Investig. Allergol. Clin. Immunol. 2000 10 : 372 4.
10. Yoshizawa A Araki Y Kobayashi N Kudo K. A case of aminophylline hypersensitivity due to ethylenediamine. Allergy 1999 48 : 1206 11.
11. National Institute of Health/National Heart, Lung and Blood Institute. Guidelines for the Diagnosis and Management of Asthma, Expert Panel Report 2. NIH Publication No. 97-4051, 1997.
12. National Institute of Health/National Heart, Lung and Blood Institute. Global Strategy for Asthma Management and Prevention, Revised 2002. NIH Publication No. 02-3659.
13. Rodgers A Woodhouse KW Bateman DN. Effects of time of dosing and age on intravenous aminophylline pharmacokinetics. Br. J. Clin. Pharmacol. 1987 23 : 344 7.
14. Shin SG Juan D Rammohan M. Theophylline pharmacokinetics in normal elderly subjects. Clin. Pharmacol. Ther. 1988 44 : 522 30.
15. Borg GAV. Psychophysical bases of perceived exertion. Med. Sci. Sports Exerc. 1982 14 : 377 81.
16. Jonsson S Kjartansson G Gislason D Helgason H. Comparison of the oral and intravenous routes for treating asthma with methylprednisolone and theophylline. Chest 1988 94 : 723 6.
17. Hendeles L Weinberger M. Theophylline. A 'state of the art' review. Pharmacotherapy 1983 3 : 2 44.
18. Rabe KF Dent G. Theophylline and airway inflammation. Clin. Exp. Allergy 1998 28 ( Suppl. 3 35 41.
19. Ohta K Sawamoto S Nakajima M et al. The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis. Clin. Exp. Allergy 1996 26 ( Suppl. 2 10 15.
20. Ito K Lim S Caramori G et al. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc. Natl. Acad. Sci. USA 2002 99 : 8921 6.
21. Gauthier AP Yan S Sliwinski P Macklem PT. Effects of fatigue, fiber length, and aminophylline on human diaphragm contractility. Am. J. Respir. Crit. Care Med. 1995 152 : 204 10.
22. Kamada AK. Therapeutic controversies in the treatment of asthma. Ann. Pharmacother. 1994 28 : 904 14.
23. Hall KW Dobson KE Dalton JG Ghignone MC Penner SB. Metabolic abnormalities associated with intentional theophylline overdose. Ann. Intern. Med. 1984 101 : 457 62.
24. Kato M Tatsuta H Okada K Sakamoto K Morita H. Comparative effect of theophylline and aminophylline on theophylline blood concentrations and peripheral blood eosinophils in patients with asthma. Drugs Exp. Clin. Res. 2001 27 : 83 8.